{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:35:32Z","timestamp":1771580132964,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T00:00:00Z","timestamp":1361836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00520-013-1762-2","type":"journal-article","created":{"date-parts":[[2013,2,25]],"date-time":"2013-02-25T04:11:00Z","timestamp":1361765460000},"page":"2049-2057","source":"Crossref","is-referenced-by-count":15,"title":["Weight changes correlate with alterations in subjective physical function in advanced cancer patients referred to a specialized nutrition and rehabilitation team"],"prefix":"10.1007","volume":"21","author":[{"given":"Monica P.","family":"Parmar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Thomas","family":"Jagoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,26]]},"reference":[{"key":"1762_CR1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","volume":"34","author":"HJ Andreyev","year":"1998","unstructured":"Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503\u2013509","journal-title":"Eur J Cancer"},{"key":"1762_CR2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","volume":"69","author":"WD Dewys","year":"1980","unstructured":"Dewys WD, Begg C, Lavin PT et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491\u2013497","journal-title":"Am J Med"},{"key":"1762_CR3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross PJ, Ashley S, Norton A et al (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90:1905\u20131911","journal-title":"Br J Cancer"},{"key":"1762_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1207\/S15327914NC3701_4","volume":"37","author":"P O'Gorman","year":"2000","unstructured":"O'Gorman P, Mcmillan DC, McArdle CS (2000) Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37:36\u201340","journal-title":"Nutr Cancer"},{"key":"1762_CR5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00520-001-0318-z","volume":"10","author":"D Walsh","year":"2002","unstructured":"Walsh D, Rybicki L, Nelson KA, Donnelly S (2002) Symptoms and prognosis in advanced cancer. Support Care Cancer 10:385\u2013388","journal-title":"Support Care Cancer"},{"key":"1762_CR6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CMM Prado","year":"2008","unstructured":"Prado CMM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629\u2013635","journal-title":"Lancet Oncol"},{"key":"1762_CR7","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","volume":"24","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, Barber MD, Moses AG et al (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24:3401\u20133407","journal-title":"J Clin Oncol"},{"key":"1762_CR8","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","volume":"90","author":"AW Moses","year":"2004","unstructured":"Moses AW, Slater C, Preston T, Barber MD, Fearon K (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:996\u20131002","journal-title":"Br J Cancer"},{"key":"1762_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1207\/S15327914NC352_5","volume":"35","author":"P O'Gorman","year":"1999","unstructured":"O'Gorman P, Mcmillan DC, McArdle CS (1999) Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer 35:127\u2013129","journal-title":"Nutr Cancer"},{"key":"1762_CR10","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ et al (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15:2920\u20132926","journal-title":"Clin Cancer Res"},{"key":"1762_CR11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"KC Fearon","year":"2011","unstructured":"Fearon KC, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"1762_CR12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","volume":"83","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, Voss AC, Hustead DS, Group CCS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345\u20131350","journal-title":"Am J Clin Nutr"},{"key":"1762_CR13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijnurstu.2008.10.012","volume":"46","author":"J Reid","year":"2009","unstructured":"Reid J, McKenna H, Fitzsimons D, McCance T (2009) The experience of cancer cachexia: a qualitative study of advanced cancer patients and their family members. Int J Nurs Stud 46:606\u2013616","journal-title":"Int J Nurs Stud"},{"key":"1762_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2011.12.435","volume":"124","author":"A Macci\u00f2","year":"2012","unstructured":"Macci\u00f2 A, Madeddu C, Gramignano G et al (2012) A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol 124:417\u2013425","journal-title":"Gynecol Oncol"},{"key":"1762_CR15","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.20160","volume":"100","author":"K Lundholm","year":"2004","unstructured":"Lundholm K, Daneryd P, Bosaeus I, K\u00f6rner U, Lindholm E (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 100:1967\u20131977","journal-title":"Cancer"},{"key":"1762_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clnu.2006.10.005","volume":"26","author":"P Ravasco","year":"2007","unstructured":"Ravasco P, Monteiro Grillo I, Camilo M (2007) Cancer wasting and quality of life react to early individualized nutritional counselling! Clin Nutr 26:7\u201315","journal-title":"Clin Nutr"},{"key":"1762_CR17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.bjc.6601962","volume":"91","author":"EA Isenring","year":"2004","unstructured":"Isenring EA, Capra S, Bauer JD (2004) Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 91:447\u2013452","journal-title":"Br J Cancer"},{"key":"1762_CR18","first-page":"234","volume":"6","author":"TR Halfdanarson","year":"2008","unstructured":"Halfdanarson TR, Thordardottir E, West CP, Jatoi A (2008) Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol 6:234\u2013237","journal-title":"J Support Oncol"},{"key":"1762_CR19","doi-asserted-by":"crossref","first-page":"b3410","DOI":"10.1136\/bmj.b3410","volume":"339","author":"L Adamsen","year":"2009","unstructured":"Adamsen L, Quist M, Andersen C et al (2009) Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. Br Med J 339:b3410","journal-title":"Br Med J"},{"key":"1762_CR20","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","volume":"25","author":"KS Courneya","year":"2007","unstructured":"Courneya KS, Segal RJ, Mackey JR et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25:4396\u20134404","journal-title":"J Clin Oncol"},{"key":"1762_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2007.15.4963","volume":"27","author":"RJ Segal","year":"2009","unstructured":"Segal RJ, Reid RD, Courneya KS et al (2009) Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27:344\u2013351","journal-title":"J Clin Oncol"},{"key":"1762_CR22","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1136\/bmj.e70","volume":"344","author":"DYT Fong","year":"2012","unstructured":"Fong DYT, Ho JWC, Hui BPH et al (2012) Physical activity for cancer survivors: meta-analysis of randomised controlled trials. Br Med J 344:e70","journal-title":"Br Med J"},{"key":"1762_CR23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.critrevonc.2010.10.004","volume":"80","author":"D Blum","year":"2011","unstructured":"Blum D, Omlin A, Baracos VE et al (2011) Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 80:114\u2013144","journal-title":"Crit Rev Oncol Hematol"},{"key":"1762_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00520-009-0800-6","volume":"18","author":"D Blum","year":"2010","unstructured":"Blum D, Omlin A, Fearon K et al (2010) Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 18:273\u2013279","journal-title":"Support Care Cancer"},{"key":"1762_CR25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","volume":"44","author":"KCH Fearon","year":"2008","unstructured":"Fearon KCH (2008) Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44:1124\u20131132","journal-title":"Eur J Cancer"},{"key":"1762_CR26","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/0899-9007(95)00067-4","volume":"12","author":"FD Ottery","year":"1996","unstructured":"Ottery FD (1996) Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12:S15\u2013S19","journal-title":"Nutrition"},{"key":"1762_CR27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6\u20139","journal-title":"J Palliat Care"},{"key":"1762_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1207\/S15327914NC352_2","volume":"35","author":"MD Barber","year":"1999","unstructured":"Barber MD, Ross JA, Fearon KC (1999) Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35:106\u2013110","journal-title":"Nutr Cancer"},{"key":"1762_CR29","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpainsymman.2009.09.021","volume":"39","author":"E Fabbro Del","year":"2010","unstructured":"Del Fabbro E, Hui D, Nooruddin ZI et al (2010) Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report. J Pain Symp Manag 39:1016\u20131024","journal-title":"J Pain Symp Manag"},{"key":"1762_CR30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1016670403148","volume":"9","author":"JM Ribaudo","year":"2001","unstructured":"Ribaudo JM, Cella D, Hahn EA et al (2001) Re-validation and shortening of the Functional Assessment of Anorexia\/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 9:1137\u20131146","journal-title":"Qual Life Res"},{"key":"1762_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpainsymman.2009.06.010","volume":"39","author":"D Selby","year":"2010","unstructured":"Selby D, Cascella A, Gardiner K et al (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symp Manag 39:241\u2013249","journal-title":"J Pain Symp Manag"},{"key":"1762_CR32","first-page":"17","volume":"65","author":"M Dittmar","year":"2002","unstructured":"Dittmar M, Raschka C, Koch HJ (2002) Effect of diurnal variation on body composition under consideration of selected chronobiological marker systems. Prz Antropol\u2014Anthropol Rev 65:17\u201326","journal-title":"Prz Antropol\u2014Anthropol Rev"},{"key":"1762_CR33","unstructured":"R Development Core Team (2012) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing"},{"key":"1762_CR34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269216307087659","volume":"22","author":"C Nekolaichuk","year":"2008","unstructured":"Nekolaichuk C, Watanabe S, Beaumont C (2008) The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991\u20132006). Palliat Med 22:111\u2013122","journal-title":"Palliat Med"},{"key":"1762_CR35","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.ki.5000184","volume":"69","author":"SN Davison","year":"2006","unstructured":"Davison SN, Jhangri GS, Johnson JA (2006) Cross-sectional validity of a modified Edmonton Symptom Assessment System in dialysis patients: a simple assessment of symptom burden. Kidney Int 69:1621\u20131625","journal-title":"Kidney Int"},{"key":"1762_CR36","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5","volume":"88","author":"VT Chang","year":"2000","unstructured":"Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88:2164\u20132171","journal-title":"Cancer"},{"key":"1762_CR37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00520-008-0522-1","volume":"17","author":"S Watanabe","year":"2009","unstructured":"Watanabe S, Nekolaichuk C, Beaumont C, Mawani A (2009) The Edmonton symptom assessment system\u2014what do patients think? Support Care Cancer 17:675\u2013683","journal-title":"Support Care Cancer"},{"key":"1762_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2011.03.006","volume":"43","author":"JWL Keogh","year":"2012","unstructured":"Keogh JWL, MacLeod RD (2012) Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symp Manag 43:96\u2013110","journal-title":"J Pain Symp Manag"},{"key":"1762_CR39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lungcan.2011.05.026","volume":"75","author":"CJ Peddle-McIntyre","year":"2012","unstructured":"Peddle-McIntyre CJ, Bell G, Fenton D, McCargar L, Courneya KS (2012) Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors. Lung Cancer 75:126\u2013132","journal-title":"Lung Cancer"},{"key":"1762_CR40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2354.2009.01124.x","volume":"19","author":"J Reid","year":"2010","unstructured":"Reid J, McKenna HP, Fitzsimons D, McCance TV (2010) An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals. Eur J Cancer Care 19:682\u2013689","journal-title":"Eur J Cancer Care"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-1762-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1762-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T02:33:11Z","timestamp":1562725991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-1762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,26]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-1762-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,26]]}}}